"10.1371_journal.pone.0069190","plos one","2013-07-23T00:00:00Z","Alisdair McNeill; Ruey-Meei Wu; Kai-Yuan Tzen; Patricia C Aguiar; Jose M Arbelo; Paolo Barone; Kailash Bhatia; Orlando Barsottini; Vincenzo Bonifati; Sevasti Bostantjopoulou; Rodrigo Bressan; Giovanni Cossu; Pietro Cortelli; Andre Felicio; Henrique B Ferraz; Joanna Herrera; Henry Houlden; Marcelo Hoexter; Concepcion Isla; Andrew Lees; Oswaldo Lorenzo-Betancor; Niccolo E Mencacci; Pau Pastor; Sabina Pappata; Maria Teresa Pellecchia; Laura Silveria-Moriyama; Andrea Varrone; Tom Foltynie; Anthony H V Schapira","Department of Clinical Neurosciences, Institute of Neurology, University College London, London, United Kingdom; Regional Genetics Unit, Department of Clinical Genetics, Birmingham Women’s Hospital, Birmingham, United Kingdom; Department of Neurology, National Taiwan University Hospital, College of Medicine, Taipei, Taiwan; Department of Nuclear Medicine, National Taiwan University Hospital, College of Medicine, Taipei, Taiwan; Instituto Israelita de Ensino e Pesquisa Albert Einstein, Hospital Israelita Albert Einstein, São Paulo, São Paulo, Brasil; Parkinson's and Movement Disorders Unit, Department of Neurology, Hospital Universitario Insular de Gran Canaria, Las Palmas de Gran Canaria, Spain; Center for Neurodegenerative Diseases, University of Salerno, Fisciano Province of Salerno, Italy; Sobell Department of Motor Science, Institute of Neurology, University College London, London, United Kingdom; Department of Neurology, Universidade Federal de São Paulo, São Paulo, São Paulo, Brazil; Department of Clinical Genetics, Erasmus Medical Centre, Rotterdam, The Netherlands; Third Department of Neurology, G. Papanikolaou Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece; Neurology Service and Stroke Unit, General Hospital S. Michele AOB G. Brotzu, Cagliari, Italy; Department of Biomedical and Neuromotor Sciences, University of Bologna, Bologna, Italy; Division of Movement Disorders, Universidade Federal de São Paulo (UNIFESP), Escola Paulista de Medicina (EPM), São Paulo, São Paulo, Brazil; Department of Molecular Neuroscience, UCL Institute of Neurology, London, United Kingdom; Neurogenetics Laboratory, Division of Neurosciences, Center for Applied Medical Research, University of Navarra, Pamplona, Spain; Institute of Biostructure and Bioimaging, CNR, Naples, Italy; Karolinska Institutet, Department of Clinical Neuroscience, Centre for Psychiatry Research, Stockholm, Sweden","Conceived and designed the experiments: AM AHVS. Performed the experiments: AM SB. Analyzed the data: AM SB. Contributed reagents/materials/analysis tools: AM RMW KYT PCA JMA PB KB OB VB SB RB GC PC AF HBF JH HH MH CI AL OLB NEM PP SP MTP LSM AV TF AHVS. Wrote the paper: AM AHVS.","Below are the authors' declarations of funding sources, including commercial funders: Rueey-Mei Wu - Analysis of data, revising manuscript. Government research support National Science Council (96-2628-B-002-102-MY3), academic research support not attributed in manuscript National Science Council (98-2628-B-002-072-MY3) National Taiwan University Hospital (100-S1636), on editorial boards Parkinsonism and related disorders, Journal of Formosan Medical Association, Acta Neurologica Taiwanica and no conflicts of interest. Patricia Aguiar - Analysis and interpretation of data. Funding for travel from Roche, government research support FAPESP (grants 2010/19206-0; 2011/18202-3; 2011/14116-5, research grant from Edmond J Safra foundation and no conflicts of interest. Rodrigo Bressan - Analysis and interpretation of data. Research funding from Janssen, Eli Lily, Lundbeck, Novartis, Roche, FAPESP, CNPq, CAPES, Fundação Safra, Fundação ABADS. Shareholder in Radiopharmacus Ltda, Biomolecular Technology Ltda. Speaking fees from Astra Zeneca, Bristol, Janssen, Lundbeck, Roche. No conflicts of interest. Andre Felicio - Analysis and interpretation of data. funding for travel from Roche, Honoraria from Gerson Lehrman group, research funding from Parkinson's society Canada and no conflicts of interest. Henrique Ferraz - Analysis and interpretation of data. Funding for travel from Roche and Novartis and no conflicts of interest. Andrew Lees -Andrew Lees discloses financial support from the Reta Lila Weston Trust, University College London, Parkinson's UK and PSP Association. He is on the specialist board for Novartis, Teva, Meda, Boehringer Ingelheim, GSK, Ipsen, Lundbeck, Allergan, Orion, BIAL, Noscira, Roche, has received consultancy fees from Genus, and honoraria from Novartis, Teva, Meda, Boehringer Ingelheim, GSK, Ipsen, Lundbeck, Allergan, Orion, BIAL, Noscira and Roche. Laura Silveria-Moriyama - Analysis and interpretation of data. Laura Silveira-Moriyama discloses financial support from the Reta Lila Weston Trust, University College London, University of Campinas, Parkinson's UK and Virginia Keiley Benefaction, and travels grants from UCB, Teva and Boehringer-Ingelheim. Tom Foltynie - Analysis and interpretation of data. Honoraria for speaking at meetings sponsored by St Jude medical, Abbott, Novartis. Grant support from Parkinson's UK, Cure Parkinson's Trust, the European Union and the Brain Research Trust. Anthony HV Schapira - Study design, analysis and interpretation of data, revising manuscript. Receives funding from the United Kingdom Medical Research Council, Wellcome Trust, Parkinson's UK and Kattan Trust. Specialist boards and educational symposia for Orion-Novartis, Teva-Lundbeck, Merck, BI, UCB. AH Schapira is an NIHR Senior Investigator. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.","2013","07","Alisdair McNeill","AMN",29,TRUE,2,2,2,2,TRUE,TRUE,FALSE,0,NA,FALSE
